Moreover, induced MMR deficiency decreases MHC class I-related and B2M gene expression in neuroblastoma cells, rendering them less sensitive to CD8+ T cell cytotoxicity and potentially anti-PD1 therapy. The gene discussed is B2M; the disease is mismatch repair cancer syndrome 1.